On 21 October 2002, orphan designation (EU/3/02/116) was granted by the European Commission to Liponova GmbH, Germany, for autologous renal tumour vaccine for the treatment of renal cell carcinoma.
Autologous Renal Cell Tumour Vaccine
|Disease / condition||
Treatment of renal cell carcinoma
|Date of decision||
|Orphan decision number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.